APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-Invasive Prenatal Screening (NIPS)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Non-Invasive Prenatal Screening (NIPS) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

11 April 2026195 pages

Choose your research edition.

Industry ResearchNon-Invasive Prenatal Screening (NIPS) Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-Invasive Prenatal Screening (NIPS) Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Non-Invasive Prenatal Screening (NIPS) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-Invasive Prenatal Screening (NIPS) Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Non-Invasive Prenatal Screening (NIPS) Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Non-Invasive Prenatal Screening (NIPS) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Non-Invasive Prenatal Screening (NIPS) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-Invasive Prenatal Screening (NIPS) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-Invasive Prenatal Screening (NIPS) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Non-Invasive Prenatal Screening (NIPS) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non-Invasive Prenatal Screening (NIPS) include Revvity, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, SYNLAB, Veritas Genetics, GGA, Cordlife and BGI Genomics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Non-Invasive Prenatal Screening (NIPS) market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-Invasive Prenatal Screening (NIPS) and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-Invasive Prenatal Screening (NIPS) revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Non-Invasive Prenatal Screening (NIPS) market size, projected growth trends, production technologies, key applications, and end-use industries.

Non-Invasive Prenatal Screening (NIPS) Segment by Company

Revvity

Quest Diagnostics

MedGenome

Mayo Clinic Laboratories

SYNLAB

Veritas Genetics

GGA

Cordlife

BGI Genomics

Berry Genomics

Annaroad

Genesky

Weihansi Biomedical Technology

Non-Invasive Prenatal Screening (NIPS) Segment by Type

Screening in Uncomplicated Pregnancies

Screening in High-Risk Pregnancies

Others

Non-Invasive Prenatal Screening (NIPS) Segment by Application

Public Hospitals

Private Hospitals

Non-Invasive Prenatal Screening (NIPS) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Invasive Prenatal Screening (NIPS) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-Invasive Prenatal Screening (NIPS) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Invasive Prenatal Screening (NIPS).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Non-Invasive Prenatal Screening (NIPS) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non-Invasive Prenatal Screening (NIPS) industry.

Chapter 3: Detailed analysis of Non-Invasive Prenatal Screening (NIPS) companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-Invasive Prenatal Screening (NIPS)revenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Screening in Uncomplicated Pregnancies Table 3. Key Players of Screening in High-Risk Pregnancies Table 4. Key Players of Others Table 4. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Public Hospitals Table 6. Key Players of Private Hospitals Table 7. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Region (2021-2026) Table 10. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Region (2027-2032) Table 12. Non-Invasive Prenatal Screening (NIPS) Industry Trends Table 13. Non-Invasive Prenatal Screening (NIPS) Industry Drivers Table 14. Non-Invasive Prenatal Screening (NIPS) Industry Opportunities and Challenges Table 15. Non-Invasive Prenatal Screening (NIPS) Industry Restraints Table 16. Global Non-Invasive Prenatal Screening (NIPS) Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Company (2021-2026) Table 18. Global Non-Invasive Prenatal Screening (NIPS) Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Non-Invasive Prenatal Screening (NIPS) Key Company Head Office and Area Served Table 20. Global Non-Invasive Prenatal Screening (NIPS) Company, Product Type & Application Table 21. Global Non-Invasive Prenatal Screening (NIPS) Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Non-Invasive Prenatal Screening (NIPS) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Type (2021-2026) Table 28. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Type (2027-2032) Table 29. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Application (2021-2026) Table 33. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Application (2027-2032) Table 34. Revvity Company Information Table 35. Revvity Business Overview Table 36. Revvity Non-Invasive Prenatal Screening (NIPS) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Revvity Non-Invasive Prenatal Screening (NIPS) Product Portfolio Table 38. Revvity Recent Development Table 39. Quest Diagnostics Company Information Table 40. Quest Diagnostics Business Overview Table 41. Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Product Portfolio Table 43. Quest Diagnostics Recent Development Table 44. MedGenome Company Information Table 45. MedGenome Business Overview Table 46. MedGenome Non-Invasive Prenatal Screening (NIPS) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. MedGenome Non-Invasive Prenatal Screening (NIPS) Product Portfolio Table 48. MedGenome Recent Development Table 49. Mayo Clinic Laboratories Company Information Table 50. Mayo Clinic Laboratories Business Overview Table 51. Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Product Portfolio Table 53. Mayo Clinic Laboratories Recent Development Table 54. SYNLAB Company Information Table 55. SYNLAB Business Overview Table 56. SYNLAB Non-Invasive Prenatal Screening (NIPS) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. SYNLAB Non-Invasive Prenatal Screening (NIPS) Product Portfolio Table 58. SYNLAB Recent Development Table 59. Veritas Genetics Company Information Table 60. Veritas Genetics Business Overview Table 61. Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Product Portfolio Table 63. Veritas Genetics Recent Development Table 64. GGA Company Information Table 65. GGA Business Overview Table 66. GGA Non-Invasive Prenatal Screening (NIPS) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. GGA Non-Invasive Prenatal Screening (NIPS) Product Portfolio Table 68. GGA Recent Development Table 69. Cordlife Company Information Table 70. Cordlife Business Overview Table 71. Cordlife Non-Invasive Prenatal Screening (NIPS) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Cordlife Non-Invasive Prenatal Screening (NIPS) Product Portfolio Table 73. Cordlife Recent Development Table 74. BGI Genomics Company Information Table 75. BGI Genomics Business Overview Table 76. BGI Genomics Non-Invasive Prenatal Screening (NIPS) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. BGI Genomics Non-Invasive Prenatal Screening (NIPS) Product Portfolio Table 78. BGI Genomics Recent Development Table 79. Berry Genomics Company Information Table 80. Berry Genomics Business Overview Table 81. Berry Genomics Non-Invasive Prenatal Screening (NIPS) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Berry Genomics Non-Invasive Prenatal Screening (NIPS) Product Portfolio Table 83. Berry Genomics Recent Development Table 84. Annaroad Company Information Table 85. Annaroad Business Overview Table 86. Annaroad Non-Invasive Prenatal Screening (NIPS) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Annaroad Non-Invasive Prenatal Screening (NIPS) Product Portfolio Table 88. Annaroad Recent Development Table 89. Genesky Company Information Table 90. Genesky Business Overview Table 91. Genesky Non-Invasive Prenatal Screening (NIPS) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Genesky Non-Invasive Prenatal Screening (NIPS) Product Portfolio Table 93. Genesky Recent Development Table 94. Weihansi Biomedical Technology Company Information Table 95. Weihansi Biomedical Technology Business Overview Table 96. Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Product Portfolio Table 98. Weihansi Biomedical Technology Recent Development Table 99. North America Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026) & (US$ Million) Table 100. North America Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2027-2032) & (US$ Million) Table 101. North America Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026) & (US$ Million) Table 102. North America Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2027-2032) & (US$ Million) Table 103. North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021-2026) Table 105. North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2027-2032) Table 106. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026) & (US$ Million) Table 107. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2027-2032) & (US$ Million) Table 108. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026) & (US$ Million) Table 109. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2027-2032) & (US$ Million) Table 110. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021-2026) Table 112. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2027-2032) Table 113. China Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026) & (US$ Million) Table 114. China Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2027-2032) & (US$ Million) Table 115. China Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026) & (US$ Million) Table 116. China Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2027-2032) & (US$ Million) Table 117. Asia Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026) & (US$ Million) Table 118. Asia Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2027-2032) & (US$ Million) Table 119. Asia Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026) & (US$ Million) Table 120. Asia Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2027-2032) & (US$ Million) Table 121. Asia Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Asia Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021-2026) Table 123. Asia Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2027-2032) Table 124. South America, Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026) & (US$ Million) Table 125. South America, Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2027-2032) & (US$ Million) Table 126. South America, Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026) & (US$ Million) Table 127. South America, Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2027-2032) & (US$ Million) Table 128. South America, Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. South America, Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021-2026) Table 130. South America, Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2027-2032) Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Non-Invasive Prenatal Screening (NIPS) Product Image Figure 2. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Type: 2025 VS 2032 Figure 4. Screening in Uncomplicated Pregnancies Image Figure 5. Screening in High-Risk Pregnancies Image Figure 6. Others Image Figure 7. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Application: 2025 VS 2032 Figure 9. Public Hospitals Image Figure 10. Private Hospitals Image Figure 11. Global Non-Invasive Prenatal Screening (NIPS) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 13. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Non-Invasive Prenatal Screening (NIPS) Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Type (2021-2032) Figure 20. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Application (2021-2032) Figure 22. North America Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 23. North America Non-Invasive Prenatal Screening (NIPS) Market Share by Type (2021-2032) Figure 24. North America Non-Invasive Prenatal Screening (NIPS) Market Share by Application (2021-2032) Figure 25. North America Non-Invasive Prenatal Screening (NIPS) Market Share by Country (2021-2032) Figure 26. United States Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 27. Canada Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 29. Europe Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 30. Europe Non-Invasive Prenatal Screening (NIPS) Market Share by Type (2021-2032) Figure 31. Europe Non-Invasive Prenatal Screening (NIPS) Market Share by Application (2021-2032) Figure 32. Europe Non-Invasive Prenatal Screening (NIPS) Market Share by Country (2021-2032) Figure 33. Germany Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 34. France Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 36. Italy Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 37. Russia Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 39. China Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 40. China Non-Invasive Prenatal Screening (NIPS) Market Share by Type (2021-2032) Figure 41. China Non-Invasive Prenatal Screening (NIPS) Market Share by Application (2021-2032) Figure 42. Asia Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 43. Asia Non-Invasive Prenatal Screening (NIPS) Market Share by Type (2021-2032) Figure 44. Asia Non-Invasive Prenatal Screening (NIPS) Market Share by Application (2021-2032) Figure 45. Asia Non-Invasive Prenatal Screening (NIPS) Market Share by Country (2021-2032) Figure 46. Japan Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 50. India Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 51. Australia Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Share by Country (2021-2032) Figure 56. Brazil Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 61. UAE Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 63. Chile Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Screening in Uncomplicated Pregnancies
  • Screening in High-Risk Pregnancies
  • Others
Applications
  • Public Hospitals
  • Private Hospitals
Companies covered
  • Revvity
  • Quest Diagnostics
  • MedGenome
  • Mayo Clinic Laboratories
  • SYNLAB
  • Veritas Genetics
  • GGA
  • Cordlife
  • BGI Genomics
  • Berry Genomics
  • Annaroad
  • Genesky
  • Weihansi Biomedical Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Screening in Uncomplicated Pregnancies
  5. 1.2.3 Screening in High-Risk Pregnancies
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Public Hospitals
  10. 1.3.3 Private Hospitals
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Non-Invasive Prenatal Screening (NIPS) Growth Trends by Region
  13. 1.5.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2021-2026)
  15. 1.5.3 Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Non-Invasive Prenatal Screening (NIPS) Market Dynamics
  1. 2.1 Non-Invasive Prenatal Screening (NIPS) Industry Trends
  2. 2.2 Non-Invasive Prenatal Screening (NIPS) Industry Drivers
  3. 2.3 Non-Invasive Prenatal Screening (NIPS) Industry Opportunities and Challenges
  4. 2.4 Non-Invasive Prenatal Screening (NIPS) Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Non-Invasive Prenatal Screening (NIPS) Revenue by Company (2021-2026)
  2. 3.2 Global Non-Invasive Prenatal Screening (NIPS) Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Non-Invasive Prenatal Screening (NIPS) Key Company Head office and Area Served
  4. 3.4 Global Non-Invasive Prenatal Screening (NIPS) Company, Product Type & Application
  5. 3.5 Global Non-Invasive Prenatal Screening (NIPS) Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Non-Invasive Prenatal Screening (NIPS) Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Non-Invasive Prenatal Screening (NIPS) Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Non-Invasive Prenatal Screening (NIPS) Tier 1, Tier 2, and Tier 3
4 Non-Invasive Prenatal Screening (NIPS) Market by Type
  1. 4.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2032)
  3. 4.3 Global Non-Invasive Prenatal Screening (NIPS) Market Size Share by Type (2021-2032)
5 Non-Invasive Prenatal Screening (NIPS) Market by Application
  1. 5.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2032)
  3. 5.3 Global Non-Invasive Prenatal Screening (NIPS) Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Revvity
  2. 6.1.1 Revvity Company Information
  3. 6.1.2 Revvity Business Overview
  4. 6.1.3 Revvity Non-Invasive Prenatal Screening (NIPS) Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Revvity Non-Invasive Prenatal Screening (NIPS) Product Portfolio
  6. 6.1.5 Revvity Recent Developments
  7. 6.2 Quest Diagnostics
  8. 6.2.1 Quest Diagnostics Company Information
  9. 6.2.2 Quest Diagnostics Business Overview
  10. 6.2.3 Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Product Portfolio
  12. 6.2.5 Quest Diagnostics Recent Developments
  13. 6.3 MedGenome
  14. 6.3.1 MedGenome Company Information
  15. 6.3.2 MedGenome Business Overview
  16. 6.3.3 MedGenome Non-Invasive Prenatal Screening (NIPS) Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 MedGenome Non-Invasive Prenatal Screening (NIPS) Product Portfolio
  18. 6.3.5 MedGenome Recent Developments
  19. 6.4 Mayo Clinic Laboratories
  20. 6.4.1 Mayo Clinic Laboratories Company Information
  21. 6.4.2 Mayo Clinic Laboratories Business Overview
  22. 6.4.3 Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Product Portfolio
  24. 6.4.5 Mayo Clinic Laboratories Recent Developments
  25. 6.5 SYNLAB
  26. 6.5.1 SYNLAB Company Information
  27. 6.5.2 SYNLAB Business Overview
  28. 6.5.3 SYNLAB Non-Invasive Prenatal Screening (NIPS) Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 SYNLAB Non-Invasive Prenatal Screening (NIPS) Product Portfolio
  30. 6.5.5 SYNLAB Recent Developments
  31. 6.6 Veritas Genetics
  32. 6.6.1 Veritas Genetics Company Information
  33. 6.6.2 Veritas Genetics Business Overview
  34. 6.6.3 Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Product Portfolio
  36. 6.6.5 Veritas Genetics Recent Developments
  37. 6.7 GGA
  38. 6.7.1 GGA Company Information
  39. 6.7.2 GGA Business Overview
  40. 6.7.3 GGA Non-Invasive Prenatal Screening (NIPS) Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 GGA Non-Invasive Prenatal Screening (NIPS) Product Portfolio
  42. 6.7.5 GGA Recent Developments
  43. 6.8 Cordlife
  44. 6.8.1 Cordlife Company Information
  45. 6.8.2 Cordlife Business Overview
  46. 6.8.3 Cordlife Non-Invasive Prenatal Screening (NIPS) Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Cordlife Non-Invasive Prenatal Screening (NIPS) Product Portfolio
  48. 6.8.5 Cordlife Recent Developments
  49. 6.9 BGI Genomics
  50. 6.9.1 BGI Genomics Company Information
  51. 6.9.2 BGI Genomics Business Overview
  52. 6.9.3 BGI Genomics Non-Invasive Prenatal Screening (NIPS) Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 BGI Genomics Non-Invasive Prenatal Screening (NIPS) Product Portfolio
  54. 6.9.5 BGI Genomics Recent Developments
  55. 6.10 Berry Genomics
  56. 6.10.1 Berry Genomics Company Information
  57. 6.10.2 Berry Genomics Business Overview
  58. 6.10.3 Berry Genomics Non-Invasive Prenatal Screening (NIPS) Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Berry Genomics Non-Invasive Prenatal Screening (NIPS) Product Portfolio
  60. 6.10.5 Berry Genomics Recent Developments
  61. 6.11 Annaroad
  62. 6.11.1 Annaroad Company Information
  63. 6.11.2 Annaroad Business Overview
  64. 6.11.3 Annaroad Non-Invasive Prenatal Screening (NIPS) Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Annaroad Non-Invasive Prenatal Screening (NIPS) Product Portfolio
  66. 6.11.5 Annaroad Recent Developments
  67. 6.12 Genesky
  68. 6.12.1 Genesky Company Information
  69. 6.12.2 Genesky Business Overview
  70. 6.12.3 Genesky Non-Invasive Prenatal Screening (NIPS) Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Genesky Non-Invasive Prenatal Screening (NIPS) Product Portfolio
  72. 6.12.5 Genesky Recent Developments
  73. 6.13 Weihansi Biomedical Technology
  74. 6.13.1 Weihansi Biomedical Technology Company Information
  75. 6.13.2 Weihansi Biomedical Technology Business Overview
  76. 6.13.3 Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Product Portfolio
  78. 6.13.5 Weihansi Biomedical Technology Recent Developments
7 North America
  1. 7.1 North America Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032)
  2. 7.2 North America Non-Invasive Prenatal Screening (NIPS) Market Size by Type
  3. 7.2.1 North America Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026)
  4. 7.2.2 North America Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2027-2032)
  5. 7.2.3 North America Non-Invasive Prenatal Screening (NIPS) Market Share by Type (2021-2032)
  6. 7.3 North America Non-Invasive Prenatal Screening (NIPS) Market Size by Application
  7. 7.3.1 North America Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026)
  8. 7.3.2 North America Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2027-2032)
  9. 7.3.3 North America Non-Invasive Prenatal Screening (NIPS) Market Share by Application (2021-2032)
  10. 7.4 North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country
  11. 7.4.1 North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021-2026)
  13. 7.4.3 North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2027-2032)
  14. 7.4.4 North America Non-Invasive Prenatal Screening (NIPS) Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032)
  2. 8.2 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Type
  3. 8.2.1 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026)
  4. 8.2.2 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2027-2032)
  5. 8.2.3 Europe Non-Invasive Prenatal Screening (NIPS) Market Share by Type (2021-2032)
  6. 8.3 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Application
  7. 8.3.1 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026)
  8. 8.3.2 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2027-2032)
  9. 8.3.3 Europe Non-Invasive Prenatal Screening (NIPS) Market Share by Application (2021-2032)
  10. 8.4 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country
  11. 8.4.1 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021-2026)
  13. 8.4.3 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2027-2032)
  14. 8.4.4 Europe Non-Invasive Prenatal Screening (NIPS) Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032)
  2. 9.2 China Non-Invasive Prenatal Screening (NIPS) Market Size by Type
  3. 9.2.1 China Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026)
  4. 9.2.2 China Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2027-2032)
  5. 9.2.3 China Non-Invasive Prenatal Screening (NIPS) Market Share by Type (2021-2032)
  6. 9.3 China Non-Invasive Prenatal Screening (NIPS) Market Size by Application
  7. 9.3.1 China Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026)
  8. 9.3.2 China Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2027-2032)
  9. 9.3.3 China Non-Invasive Prenatal Screening (NIPS) Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032)
  2. 10.2 Asia Non-Invasive Prenatal Screening (NIPS) Market Size by Type
  3. 10.2.1 Asia Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026)
  4. 10.2.2 Asia Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2027-2032)
  5. 10.2.3 Asia Non-Invasive Prenatal Screening (NIPS) Market Share by Type (2021-2032)
  6. 10.3 Asia Non-Invasive Prenatal Screening (NIPS) Market Size by Application
  7. 10.3.1 Asia Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026)
  8. 10.3.2 Asia Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2027-2032)
  9. 10.3.3 Asia Non-Invasive Prenatal Screening (NIPS) Market Share by Application (2021-2032)
  10. 10.4 Asia Non-Invasive Prenatal Screening (NIPS) Market Size by Country
  11. 10.4.1 Asia Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021-2026)
  13. 10.4.3 Asia Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2027-2032)
  14. 10.4.4 Asia Non-Invasive Prenatal Screening (NIPS) Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst